Application progress of immunosuppresive agent in refractory nephritic syndrome in children
Qiaohuan Yang
Abstract
Qiaohuan Yang
Abstract
Refractory nephrotic syndrome(RNS) is one of the main causes of end-stage renal disease to children and also a difficult issue in clinic treatment.In recent years,the emergence of new immunosuppresive agents greatly improved the prognosis of children with RNS.In this paper,the application progress of immunosuppresive agents such as cyclophosphamide,ciclosporin,tacrolimus,mycophenolate mofetil,leflunomide and rituximab which were commonly used in recent years to different types of children with RNS are summarized. Key words: Immunosuppressive agents; Children; Refractory nephritic syndrome
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Refractory nephrotic syndrome(RNS) is one of the main causes of end-stage renal disease to children and also a difficult issue in clinic treatment.In recent years,the emergence of new immunosuppresive agents greatly improved the prognosis of children with RNS.In this paper,the application progress of immunosuppresive agents such as cyclophosphamide,ciclosporin,tacrolimus,mycophenolate mofetil,leflunomide and rituximab which were commonly used in recent years to different types of children with RNS are summarized. Key words: Immunosuppressive agents; Children; Refractory nephritic syndrome
Key concepts: Medicine, Rituximab, Nephritic syndrome, Refractory (planetary science), Leflunomide, Nephrotic syndrome, Tacrolimus, Immunology